CLARIVATE PLC

Clarivate Plc has agreed to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for an aggregate purchase price of $600 million. The consideration includes $500 million in cash, $25 million in deferred consideration, and a $75 million unsecured senior note. The transaction is expected to close by the end of 2026, subject to regulatory approvals. Additionally, a retention agreement was entered into with Henry Levy, President of the divested business, ensuring full vesting of his unvested restricted stock units upon the transaction's closing.

Clarivate Plc announced a definitive agreement to divest its Life Sciences & Healthcare segment to an affiliate of Altaris, LLC for $600 million. The company intends to use the cash proceeds to reduce debt, aiming to strengthen its balance sheet and improve its financial profile by increasing recurring revenue mix, expanding Adjusted EBITDA margin, and lowering capital intensity. Clarivate reaffirmed its full-year 2026 financial outlook, with the transaction expected to close by year-end 2026.

Clarivate Plc announced the appointment of Simon Webster as President of its Intellectual Property (IP) segment, effective June 10, 2026. Webster, former CEO of CPA Global, brings over two decades of leadership and expertise in the global IP ecosystem. He succeeds Maroun S. Mourad, who will depart from his position on June 9, 2026, and remain in an advisory role until September 30, 2026, receiving a $450,000 pro-rated bonus. The company also reaffirmed its full-year 2026 outlook.

Clarivate Plc held its 2026 Annual General Meeting of Shareholders on May 14, 2026, where a quorum of 559,077,435 ordinary shares was present. All three proposals presented to the shareholders were approved. This included the election of ten directors, the advisory approval of executive compensation, and the reappointment of PricewaterhouseCoopers LLP as the company's independent registered public accountants for fiscal year 2026. The company also announced that its 2027 Annual General Meeting will be held on May 6, 2027.

Clarivate Plc reported a significant improvement in its Q1 2026 financial results, with net loss narrowing to $(40.2)M from $(103.9)M in the prior year, and operating income turning positive to $30.2M from a $(20.8)M loss. This improvement occurred despite a slight revenue decrease of 1.4% to $585.5M. The company also actively managed its debt, redeeming $100.0M in Senior Secured Notes and repurchasing additional debt for a gain.

Clarivate Plc reported Q1 2026 results, with total revenues of $585.5 million and an adjusted net income of $119.3 million, or $0.18 adjusted diluted EPS. The company reduced debt by $143 million and reaffirmed its full-year 2026 financial outlook, including expectations for margin expansion and approximately $400 million of free cash flow. The Value Creation Plan is noted for delivering accelerated organic revenue growth and strengthening performance.